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Abstract 
Background: The increasing prevalence of multi‑drug resistant fungal infections has encouraged the search for new 
antifungal agents. Hydrazone derivatives always exhibited diversity activities, including antifungal, anti‑inflammatory, 
anti‑oxidation, anti‑cancer activity. Regarding the heterocyclic moiety, 1,2,4‑triazolo[4,3‑a]pyridine derivatives also 
display broad activities, such as antifungal activity, anticonvulsant activity, herbicidal activity, antimicrobial activity and 
anticancer activity.
Results: A series of novel 1,2,4‑triazolo[4,3‑a]pyridine derivatives containing hydrazone moiety were designed and 
synthesized from 2,3‑dichloropyridine, hydrazine hydrate by multi‑step reactions under microwave irradiation condi‑
tion, and their structures were characterized by FT IR, 1H NMR, 13C NMR, 19F NMR, MS and elemental analysis. The 
antifungal activities of title compounds were determined. The results indicated that some of the title compounds 
exhibited good antifungal activity. Furthermore, DFT calculation was carried out for studying the structure–activity 
relationship (SAR).
Conclusion: A practical synthetic route to obtain 1,2,4‑triazolo[4,3‑a]pyridine derivatives is presented. This study sug‑
gests that the 1,2,4‑triazolo[4,3‑a]pyridine derivatives exhibited good antifungal activity.
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Background
Nowadays, the synthesis of nitrogen containing hetero-
cycles is an important direction in the fields of pesticidal 
chemistry [1–3], medicinal chemistry [4], polymer chem-
istry [5], coordination chemistry [6] and industrial chem-
istry [7]. 1,2,4-Triazole derivatives and pyridine derivatives 
often display broad and diverse biological activities [8–
10]. Some reports found that fused heterocycles generally 
displayed mixed properties of the corresponding single 
heterocycles. Many references proved that the fusing of 
triazole and pyridine rings was a good way to produce 
highly active compounds, such as herbicidal [11, 12], anti-
fungal [13, 14], anticonvulsant [15], antibacterial activity 
[16]. Furthermore, the acylhydrazone structure is consid-
ered an important pharmacophore in drug discovery [17]. 
In the past years, there have been many reports in the lit-
erature for the synthesis and biological activities of hydra-
zone derivatives [18–20], such as acaricidal, anti-cancer, 
insecticidal, antifungal, antibacterial, antimicrobial and 
antileishmanial activity. In addition, hydrazones also are 
very useful starting materials in bioactive heterocycles, 
such as β-lactams, pyrazoles, and pyrazines.
In our previous work, many 1,2,4-triazolo[4,3-a]pyri-
dine derivatives were designed and synthesized, which 
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exhibit excellent and diverse activity [11–14]. In line 
with our continuous efforts to synthesize bioactive 
lead compounds for crop protection [21–27], the title 
1,2,4-triazolo[4,3-a]pyridine derivatives were designed 
and synthesized by introducing acylhydrazone pharma-
cophore into the lead compound (Scheme 1).
Results and discussion
Synthesis
The key intermediate 8-chloro-[1, 2, 4]triazolo[4,3-a]pyr-
idine-3-carbohydrazide was synthesized according to the 
Ref. [28]. Microwave technology was applied to the syn-
thetic reaction to shorten the reaction time and increase 
the yield. First, the one pot synthesis of intermediate 1 
under microwave irradiation was applied, but the result 
was not better than that of conventional condition. Then 
intermediate 1 was cyclized with diethyl oxalate lead to 
the intermediate 2 by a condensation reaction. At last, 
the 8-chloro-[1, 2, 4]triazolo[4,3-a]pyridine-3-carbohy-
drazide reacted with different aldehyde in ethanol was 
synthesized under microwave irradiation conditions. 
This reaction was completed with higher yields compared 
with the conventional mode of heating. The synthetic 
route is showed in Scheme 2.
The reaction parameters were optimized for the syn-
thesis of title compounds. The title compounds were 
prepared from 8-chloro-[1, 2, 4]triazolo[4,3-a]pyri-
dine-3-carbohydrazide and substituted aldehyde under 
microwave irradiation condition, leading to the desired 
compounds in 82–94  % yields. The compound 4d was 
chosen as a model reaction under different conditions. 
Several key reaction conditions were studied, such as 
reaction temperature, reaction times, reaction mode 
(conventional or microwave irradiation). The results are 
illustrated in Table 1. From Table 1, it is indicated that the 
microwave irradiation method allowed a shorter reac-
tion time, compared with the room temperature or reflux 
condition. Also we can see that the yield of compound 
4d is higher under microwave irradiation condition than 
that of room temperature or reflux condition. Under the 
microwave irradiation condition, the yield increase, when 
the reaction time is prolonged (10 min). Meanwhile, the 
longer reaction time held higher yield. From the Table 1, 
the best reaction condition is 78 °C and 10 min.
All the compounds were identified and characterized 
by FTIR, 1H NMR, 13C NMR, 19F NMR, MS and elemen-
tal analysis. In the 1H NMR spectra of target compounds, 
all the –NH proton signals of the title compounds can be 
found around 10–13  ppm. The appearance of signals at 
~7.0, ~7.5 and ~9.3 ppm are assigned to pyridine ring. The 
infrared spectrum of acyl hydrozone derivatives 4 showed 
absorption bands at 3139–3500  cm−1 for N–H stretch-
ing. The characteristic stretching vibrations ν (C=O) and 
ν (C=N) appears at 1657–1724, 1618–1686 cm−1 respec-
tively. Meanwhile, most of the title compounds exhibited 
the M + H+ peak in the ESI–MS results.
Antifungal activities and SAR
The antifungal activities of compound 4a–4q were evalu-
ated in vivo at 100 μg/mL against Stemphylium lycoper-
sici (Enjoji) Yamamoto (SL), Fusarium oxysporum sp. 
Cucumebrium (FO) and Botrytis cinerea (BC) and the 






















































4a: R = Ph, R'= CH3; 4b: R = CH3, R'=H; 4c: R = 2-OH-4-OCH3Ph, R'=H;
4d: R = 2-OHPh, R'=H; 4e: R =3-NO2Ph, R'=H; 4f: R = 2-OH-5-ClPh, R'=H;
4g: R = 2-OH-5-BrPh, R'=H; 4h: R =4-FPh, R'=CH3;4i: R =R = 2-OH-4-(Et2N)2Ph,
R'=H; 4j: R =4-Me2NPh, R'=H; 4k: R =Furan, R'=H; 4l: R =3,4,5-3MeOPh,
R'=H;4m: R =2-NO2Ph, R'=H;4n: R =2,4-2ClPh, R'=H;4o: R =2-MePh, R'=H;
4p: R =4-CF3Ph, R'=H; 4q: R =4-MePh, R'=H;
Scheme 2 The synthetic route of compounds 4a–4q
Table 1 Comparison of  yields of  4d through  methods 
with or without microwave irradiation
Entry Solvent Method Time (min) Temperature/°C Yield/ %
1 EtOH No‑MW 300 r.t. 90
2 EtOH No‑MW 120 Reflux 85
3 EtOH MW 1 78 68
4 EtOH MW 5 78 80
5 EtOH MW 10 78 92
6 EtOH MW 15 78 92
7 EtOH MW 10 70 78
8 EtOH MW 10 85 91
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Table 2 The antifungal activity of title compounds in vivo at 100 μg/mL
No. R Stemphylium lycopersici Fusarium oxysporum Botrytis cinerea
4a 7.14 53.89 4.44
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compound 4i(82.74  %) and 4k(83.53  %) possessed good 
activity against SL, much better than that of control 
zhongshengmycin (59.58  %). Among the other, com-
pound 4h(63.99 %), 4l(62.30 %), 4p(58.63 %), 4q(61.61 %) 
exhibited good effect against SL, they displayed a com-
parable level of activity as the control zhongshengmycin. 
For FO, compound 4k exhibited excellent effect (88.89 %), 
better than that of thiophanate-methyl(81.69  %). Mean-
while, compounds 4a, 4b, 4e, 4l, 4m, 4n, 4o, 4p and 4q 
showed moderate effect against FO with the inhibitory 
values of 53.89, 75.56, 64.44, 77.22, 70.00, 66.67, 50.00, 
69.81, 65.56  % respectively. Unfortunately, most of the 
compounds had low antifungal activities against Botrytis 
cinerea.
From Table  2, the preliminary structure and activ-
ity relationship (SAR) analysis indicated that compound 
with electron donating group at para position of benzene 
ring exhibited significant antifungal activity against SL. 
For example, compound 4h(p-F), 4l(p-N(CH3)2), 4p(p-
CF3) and 4q(p-CH3) displayed >50  % inhibitory activi-
ties. Also we found that the five-membered ring (Furan 
ring) held better activity against SL and FO than that of 
alkyl or aryl group. For the substituted salicylaldehydes, 
only compound 4i exhibited excellent antifungal activity 
against SL. On the other hand, single or poly substituted 
compounds on the benzene ring both showed good activ-
ity against FO.
DFT calculation and SAR
In order to study their structure-active relationship, we 
choose a highly active compound 4k and low activity 
compound 4c as model compounds; the frontier orbitals 
and LogP were calculated. The LogP, energy of HOMO 
and LUMO, total energy and energy gap are listed in 
Table 3.
Table 3 LogP, total energy, energy gap and frontier orbital 
energy
a ΔE = ELUMO − EHOMO
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According to the frontier molecular orbital theory, 
HOMO has the priority to provide electrons, while 
LUMO can accept electrons firstly [29, 30]. As we can see 
from Fig. 1, the LUMO and HOMO are different between 
the high active compound 4k and low active compound 
4c, especially in the orient of electron transition and 
energy gap. For the HOMO, the electron of compound 
4k is mainly concentrated on the fused 1,2,4-triazolo[4,3-
a]pyridine ring and a little on the acyl hydrazine bridge 
and furan ring, while for the compound 4c, the electron 
is mainly concentrated on the acyl hydrazine bridge 
and phenyl ring, but the fused 1,2,4-triazolo[4,3-a]
pyridine ring had no electrons. As for the LUMO, The 
electron of compound 4k is evenly distributed among 
the 1,2,4-triazolo[4,3-a]pyridine ring, acyl hydrazone 
group and furan ring. But the electron of compound 4c 
is located on the 1,2,4-triazolo[4,3-a]pyridine ring. The 
possible reasons of different antifungal activity between 
the compound 4c and 4k is electron transition direction 
and energy gap. From Fig. 1, we assumed that the com-
pound with higher energy gap exhibited higher antifun-
gal activity. Also the 1,2,4-triazolo[4,3-a]pyridine ring 
is important for the higher active compound. The other 
impact fact is LogP. From Table  1, the LogP is different 
between the two compounds.
The optimized structures of the compound 4c and 
4k are presented in Fig. 2. From Fig. 2, we can find that 
the orientations of amide groups are different. As we 
known, the conformation of compound is important for 
the biological activity due to the bind mode between 
the receptor and acceptor. So we speculate that the con-
formation of highly active compound is perpendicular 
between the 1,2,4-triazolo[4,3-a]pyridine ring and the 
aromatic ring. Otherwise, when the conformation of low 
active compound, the aromatic ring is parallel with the 
1,2,4-triazolo[4,3-a]pyridine ring. These important clues 




All the chemical reagents are analytical grade or prepared 
by our lab. Melting points were measured using an X-4 
apparatus and were uncorrected. 1H NMR spectra were 
recorded on a Bruker Avance 500  MHz spectrometer 
using DMSO-d6 as solvent. 13C NMR and 19F NMR spec-
tra were recorded on a Bruker Avance 600  MHz spec-
trometer using DMSO-d6 as solvent. Mass spectra were 
determined on a Thermo Finnigan LCQ Advantage LC/
mass detector instrument. Elemental analysis data of title 
compounds were collected by a Perkin-Elmer 240C ana-
lyzer. CEM Discover Focused Synthesizer was used to 
carry out the microwave reaction (600 W, 2450 MHz).
Synthesis
The key intermediate 1, 2, 3 are synthesized according to 
our previous work [28]. The title compounds 4a–4q was 
synthesized from the intermediate 3 and different alde-
hydes or ketones in the solution of ethanol at the condi-
tion of microwave (150 w, 78 °C, 200 psi, 10 min). All the 
other compounds are synthesized according to the pro-
cedure (Scheme 2).
8-Chloro-N′-(1-phenylethylidene)-[1,2,4]triazolo[4,3-
a]pyridine-3-carbohydrazide (4a) white yellow crystal, 
Fig. 1 Frontier molecular orbitals of compound 4c and 4k
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yield 82  %, m.p.  >  300  °C; FT-IR (KBr, cm−1): ν 3416, 
3216, 3128, 1690, 1662, 1539, 1478, 1382, 1342, 1258, 
1217, 1088, 948, 860, 794; 1H NMR (DMSO-d6, 
500  MHz), δ: 2.51(s, 3H, CH3), 7.08(t, J  =  7.0  Hz, 1H, 
Py), 7.46(s, 3H, Ar), 7.56(d, J =  7.5  Hz, 1H, Py), 7.94(s, 
2H, Ar), 9.38(d, J  =  7.0  Hz, 1H, Py), 10.35(s, 1H, NH); 
13C NMR (150 MHz, DMSO-d6) δ 15.19, 116.52, 120.83, 
125.56, 125.80, 127.11, 128.95, 129.26, 129.39, 138.06, 
139.91, 141.37, 149.04, 156.91, 168.78; MS (ESI), m/z: 
314(M+1)+. Elemental anal. For C15H12ClN5O (%), cal-
culated: C, 57.42; H, 3.86; N, 22.32; found: C, 57.65; H, 
3.76; N, 22.51.
8-Chloro-N′-ethylidene-[1,2,4]triazolo[4,3-a]pyridine-
3-carbohydrazide (4b) white yellow crystal, yield 92  %, 
m.p.  >  300  °C; FT-IR (KBr, cm−1): ν 3219, 3116, 2995, 
1724, 1686, 1578, 1491, 1239, 1109, 1039, 855, 794, 688, 
535; 1H NMR (DMSO-d6, 500 MHz), δ: 1.95(s, 3H, CH3), 
7.24(t, J =  7.2  Hz, 1H, Py), 7.82(d, J =  7.3  Hz, 1H, Py), 
9.11(d, J = 7.0 Hz, 1H, Py), 10.03(s, 1H, CH), 11.02(s, 1H, 
NH); 13C NMR (150  MHz, DMSO-d6) δ 21.04, 116.52, 
120.82, 125.55, 129.25, 139.90, 149.03, 156.90, 168.78; MS 
(ESI), m/z: 238(M+1)+. Elemental anal. For C9H8ClN5O 
(%), calculated: C, 45.49; H, 3.39; N, 29.47; found: C, 
45.55; H, 3.21; N, 29.65.
8-Chloro-N′-(2-hydroxy-4-methoxybenzylidene)-[1,2,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4c) white 
yellow crystal, yield 90  %, m.p.  >  300  °C; FT-IR (KBr, 
cm−1): ν 3500, 3141, 3083, 1709, 1677, 1631, 1606, 1508, 
1457, 1251, 1230, 1204, 1170, 1092, 1022, 965, 832, 742; 
1H NMR (DMSO-d6, 500  MHz), δ: 3.79(s, 3H, OCH3), 
6.55(d, J =  9.0 Hz, 1H, Ar), 7.25(t, J =  7.2 Hz, 1H, Py), 
7.43(d, J = 8.5 Hz, 1H, Py), 7.83(d, J = 7.3 Hz, 1H, Ar), 
8.74(s, 1H, Ar), 9.22(d, J  =  7.0  Hz, 1H, Py), 11.49(s, 
1H, CH), 11.97(s, 1H, NH), 13.01(s, 1H, OH); 13C 
NMR (150  MHz, DMSO-d6) δ 55.84, 101.69, 107.15, 
112.19, 116.42, 120.78, 125.92, 129.38, 131.79, 140.42, 
149.14, 150.93, 153.82, 160.03, 162.86; MS (ESI), m/z: 
346(M+1)+. Elemental anal. For C15H12ClN5O3 (%), cal-
culated: C, 52.11; H, 3.50; N, 20.26; found: C, 51.98; H, 
3.44; N, 20.43.
8 - C h l o r o - N ′ - ( 2 - hy dr o x yb e n z y l i d e n e) - [ 1 , 2 , 4 ]
triazolo[4,3-a]pyridine-3-carbohydrazide (4d) white yel-
low crystal, yield 92 %, m.p. > 300 °C; FT-IR (KBr, cm−1): 
ν 3178, 3143, 3052, 1667, 1619, 1549, 1486, 1445, 1354, 
1271, 1271, 1238, 1220, 1096, 1039, 954, 848, 762; 1H 
NMR (DMSO-d6, 500  MHz), δ: 6.92–6.96(m, 2H, Ar), 
7.23–7.33(m, 2H, Ar), 7.54(t, J = 7.2 Hz, 1H, Py), 7.82(s, 
1H, CH), 8.28(d, J = 7.3 Hz, 1H, Py), 9.21(d, J = 7.0 Hz, 
1H, Py), 11.13(s, 1H, NH), 13.10(s, 1H, OH); 13C NMR 
(150  MHz, DMSO-d6) δ 116.48, 116.98, 119.15, 119.94, 
120.79, 125.93, 129.43, 130.02, 132.25, 140.40, 149.17, 
150.41, 154.08, 159.03; MS (ESI), m/z: 316(M+1)+. Ele-
mental anal. For C14H10ClN5O2 (%), calculated: C, 53.26; 
H, 3.19; N, 22.18; found: C, 53.35; H, 3.22; N, 22.41.
8-Chloro-N′-(3-nitrobenzylidene)-[1,2,4]triazolo[4,3-
a]pyridine-3-carbohydrazide (4e) white yellow crystal, 
yield 94  %, m.p.  >  300  °C; FT-IR (KBr, cm−1): ν 3322, 
3158, 1683, 1620, 1533, 1486, 1451, 1353, 1275, 1214, 
1146, 1078, 959, 897, 853, 788, 736; 1H NMR (DMSO-d6, 
500 MHz), δ: 7.27(t, J = 7.0 Hz, 1H, Py), 7.73(t, J = 7.8 Hz, 
1H, Ar), 7.84–7.87(m, 2H, Py & Ar), 8.10 ~ 8.17(m, 2H, 
Ar), 9.08(s, 1H, CH), 9.21(d, J = 6.8 Hz, 1H, Py), 13.21(s, 
1H, NH); 13C NMR (150  MHz, DMSO-d6) δ 116.58, 
120.83, 121.57, 125.08, 125.87, 129.48, 131.09, 134.06, 
136.39, 140.48, 147.71, 148.75, 154.48, 162.17; MS (ESI), 
m/z: 345(M+1)+. Elemental anal. For C14H9ClN6O3 (%), 
calculated: C, 48.78; H, 2.63; N, 24.38; found: C, 48.86; H, 
2.76; N, 24.99.
8-Chloro-N′-(5-chloro-2-hydroxybenzylidene)-[1,2,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4f) white yel-
low crystal, yield 88 %, m.p. > 300 °C; FT-IR (KBr, cm−1): 
ν 3246, 3135, 1676, 1618, 1521, 1477, 1458, 1342, 1267, 
1211, 1184, 1145, 1084, 846, 724; 1H NMR (DMSO-
d6, 500  MHz), δ: 6.98(d, J  =  8.7  Hz, 1H, Ar), 7.28(t, 
J =  7.2 Hz, 1H, Py), 7.35(d, J =  8.5 Hz, 1H, Py), 7.68(s, 
1H, Ar), 7.93(d, J  =  7.4  Hz, 1H, Ar), 8.82(s, 1H, CH), 
9.21(d, J = 6.9 Hz, 1H, Py), 11.05(s, 1H, NH), 13.16(s, 1H, 
OH); 13C NMR (150  MHz, DMSO-d6) δ116.51, 118.80, 
120.80, 121.29, 123.54, 125.92, 127.86, 129.45, 131.62, 
140.41, 147.80, 149.18, 154.25, 156.59; MS (ESI), m/z: 
350(M+1)+. Elemental anal. For C14H9Cl2N5O2 (%), cal-
culated: C, 48.02; H, 2.59; N, 20.00; found: C, 47.80; H, 
2.75; N, 20.21.
N′-(5-bromo-2-hydroxybenzylidene)-8-chloro-[1,2,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4g) white yel-
low crystal, yield 90 %, m.p. > 300 °C; FT-IR (KBr, cm−1): 
ν 3249, 3134, 1674, 1619, 1613, 1519, 1473, 1455, 1341, 
1266, 1210, 1182, 1077, 958, 846, 742; 1H NMR (DMSO-
d6, 500  MHz), δ: 6.92(d, J  =  8.7  Hz, 1H, Ar), 7.27(t, 
Fig. 2 Overlay of energy‑minimized structures of 4c and 4k
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J =  7.2 Hz, 1H, Py), 7.45(d, J =  8.5 Hz, 1H, Py), 7.80(s, 
1H, Ar), 7.84(d, J  =  7.4  Hz, 1H, Ar), 8.82(s, 1H, CH), 
9.21(d, J = 6.9 Hz, 1H, Py), 11.10(s, 1H, NH), 13.15(s, 1H, 
OH); 13C NMR (150 MHz, DMSO-d6) δ 116.58, 120.83, 
121.57, 125.08, 125.87, 129.48, 131.09, 134.06, 136.39, 
140.48, 147.71, 148.75, 149.21, 154.48; MS (ESI), m/z: 
395(M+1)+. Elemental anal. For C14H9BrClN5O2 (%), cal-
culated: C, 42.61; H, 2.30; N, 17.75; found: C, 42.45; H, 
2.25; N, 17.71.
8-Chloro-N′-(1-(4-f luorophenyl)ethylidene)-[1,2,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4h) white yel-
low crystal, yield 93 %, m.p. > 300 °C; FT-IR (KBr, cm−1): 
ν 3345, 3223, 3137, 1698, 1662, 1538, 1504, 1497, 1382, 
1342, 1217, 1158, 1089, 949, 858, 794, 742; 1H NMR 
(DMSO-d6, 500 MHz), δ: 2.47(s, 3H, CH3), 7.05-7.13(m, 
3H, Ar and Py), 7.54(t, J = 7.2 Hz, 1H, Py), 7.90–7.93(m, 
2H, Ar), 9.35(d, J  =  6.9  Hz, 1H, Py), 10.31(s, 1H, NH); 
13C NMR (150 MHz, DMSO-d6) δ 15.23, 115.80, 115.93, 
116.51, 120.83, 125.55, 125.78, 129.25, 129.40, 139.91, 
149.04, 156.91, 168.78; 19F NMR (564  MHz, DMSO-d6) 
δ -111.38; MS (ESI), m/z: 332(M+1)+. Elemental anal. 
For C15H11ClFN5O (%), calculated: C, 54.31; H, 3.34; N, 
21.11; found: C, 54.18; H, 3.52; N, 21.31.
8 - C h l o r o - N ′ - ( 4 - ( d i e t h y l a m i n o ) - 2 -
hydroxybenzylidene)-[1,2,4]triazolo[4,3-a]pyridine-
3-carbohydrazide (4i) white yellow crystal, yield 92  %, 
m.p.  >300  °C; FT-IR (KBr, cm−1): ν 3212, 2970, 2931, 
1676, 1629, 1596, 1518, 1488, 1350, 1247, 1132, 1078, 
1040, 850, 758, 738; 1H NMR (DMSO-d6, 500  MHz), 
δ: 1.18–1.25(m, 6H, 2CH3), 3.36-3.42(m, 4H, 2CH2), 
6.62(m, 2H, Ar), 7.03–7.10(m, 2H, Py and Ar), 7.52(d, 
J  =  7.2  Hz, 1H, Py), 8.25(s, 1H, Ar), 8.45(s, 1H, CH), 
9.34(d, J = 7.1 Hz, 1H, Py), 10.22(s, 1H, NH); 13C NMR 
(150  MHz, DMSO-d6) δ 13.02, 44.30, 97.93, 104.31, 
106.31, 116.30, 120.75, 125.92, 129.25, 132.37, 140.55, 
149.06, 150.92, 152.06, 153.35, 160.35; MS (ESI), m/z: 
387(M+1)+. Elemental anal. For C18H19ClN6O2 (%), cal-
culated: C, 55.89; H, 4.95; N, 21.73; found: C, 55.99; H, 
4.76; N, 21.69.
8-Chloro-N′-(4-(dimethylamino)benzylidene)-[1,2,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4j) white yel-
low crystal, yield 90  %, m.p. 280–281  °C; FT-IR (KBr, 
cm−1): ν 3487, 1674, 1596, 1525, 1466, 1367, 1255, 
1189, 1087, 809, 740; 1H NMR (DMSO-d6, 500  MHz), 
δ: 2.99(s, 6H, 2CH3), 6.78(d, J = 8.8 Hz, 2H, Ar), 7.24(t, 
J = 7.2 Hz, 1H, Py), 7.54(d, J = 8.7 Hz, 1H, Ar), 7.81(d, 
J = 7.2 Hz, 1H, Py), 8.49(s, 1H, CH), 9.21(d, J = 6.9 Hz, 
1H, Py), 12.50(s, 1H, NH); 13C NMR (150 MHz, DMSO-
d6) δ 40.22, 112,25, 116.26, 120.75, 121.72, 125.86, 129.18, 
138.76, 140.77, 149.03, 150.89, 152.21, 153.69; MS (ESI), 
m/z: 343(M+1)+. Elemental anal. For C16H15ClN6O (%), 
calculated: C, 56.06; H, 4.41; N, 24.52; found: C, 55.89; H, 
4.47; N, 24.46.
8-Chloro-N′-(furan-2-ylmethylene)-[1,2,4]triazolo[4,3-
a]pyridine-3-carbohydrazide (4k) white yellow crystal, 
yield 91 %, m.p. 278–279 °C; FT-IR (KBr, cm−1): ν 3269, 
3160, 3065, 1666, 1626, 1541, 1479, 1349, 1298, 1220, 
1156, 1081, 1012, 935, 851, 803, 732; 1H NMR (DMSO-d6, 
500 MHz), δ: 6.93(d, 2H, Furan), 7.07(t, J = 6.9 Hz, 1H, 
Py), 7.54–7.57(m, 2H, Py and Furan), 8.32(s, 1H, CH), 
9.33(d, J = 6.9 Hz, 1H, Py), 11.20(s, 1H, NH); 13C NMR 
(150  MHz, DMSO-d6) δ 112.84, 114.79, 116.44, 120.77, 
125.91, 129.36, 139.57, 140.54, 146.06, 149.13, 149.74, 
154.12; MS (ESI), m/z: 290(M+1)+. Elemental anal. For 
C12H8ClN5O2 (%), calculated: C, 49.75; H, 2.78; N, 24.18; 
found: C, 49.68; H, 2.76; N, 24.44.
8-Chloro-N′-(3,4,5-trimethoxybenzylidene)-[1,2,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4l) white yel-
low crystal, yield 88 %, m.p. > 300 °C; FT-IR (KBr, cm−1): 
ν 3139, 2994, 1657, 1629, 1569, 1519, 1346, 1246, 1226, 
1066, 913, 850, 739; 1H NMR (DMSO-d6, 500  MHz), δ: 
3.96(s, 9H, 3OCH3), 7.04(s, 2H, Ar), 7.28(t, J =  7.0  Hz, 
1H, Py), 7.84(d, J  =  6.9  Hz, 1H, Py), 8.55(s, 1H, CH), 
9.21(d, J = 7.2 Hz, 1H, Py), 12.83(s, 1H, NH); 13C NMR 
(150  MHz, DMSO-d6) δ 56.46, 60.62, 104.95, 116.44, 
120.80, 125.85, 129.34, 130.05, 139.98, 139.98, 140.60, 
149.13, 153.70, 154.16; MS (ESI), m/z: 391(M+1)+. Ele-
mental anal. For C17H16ClN5O4 (%), calculated: C, 52.38; 
H, 4.14; N, 17.97; found: C, 52.51; H, 4.28; N, 8.21.
8-Chloro-N′-(2-nitrobenzylidene)-[1,2,4]triazolo[4,3-
a]pyridine-3-carbohydrazide (4m) white yellow crys-
tal, yield 90 %, m.p. >300 °C; FT-IR (KBr, cm−1): ν 3290, 
1679, 1628, 1584, 1536, 1470, 1452, 1361, 1226, 1211, 
1153, 1094, 1049, 914, 843, 743; 1H NMR (DMSO-d6, 
500 MHz), δ: 7.27(t, J = 7.0 Hz, 1H, Py), 7.72(t, J = 7.8 Hz, 
1H, Py), 7.84–7.87(m, 2H, Ar), 8.10-8.17(m, 2H, Ar), 
9.08(s, 1H, CH), 9.21(d, J = 6.8 Hz, 1H, Py), 12.21(s, 1H, 
NH); 13C NMR (150 MHz, DMSO-d6) δ 116.52, 120.81, 
125.19, 125.89, 128.63, 128.98, 129.46, 131.50, 134.29, 
140.51, 145.52, 148.85, 149.19, 154.54; MS (ESI), m/z: 
345(M+1)+. Elemental anal. For C14H9ClN6O3 (%), cal-
culated: C, 48.78; H, 2.63; N, 24.38; found: C, 48.95; H, 
2.45; N, 24.43.
8-Chloro-N ′- (2 ,4-dichlorobenzylidene)- [1 ,2 ,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4n) white yel-
low crystal, yield 91 %, m.p. >300 °C; FT-IR (KBr, cm−1): 
ν 3323, 3158, 3082, 1684, 1619, 1532, 1487, 1451, 1353, 
1214, 1146, 1078, 1048, 958, 897, 853, 788, 735, 694; 1H 
NMR (DMSO-d6, 500  MHz), δ: 7.27(t, J  =  7.0  Hz, 1H, 
Py), 7.53(d, J =  8.3 Hz, 1H, Ar), 7.74(s, 1H, Ar), 7.85(d, 
J =  7.2 Hz, 1H, Py), 8.03(d, J =  8.5 Hz, 1H, Ar), 9.05(s, 
1H, CH), 9.21(d, J =  6.9 Hz, 1H, Py), 12.13(s, 1H, NH); 
13C NMR (150  MHz, DMSO-d6) δ 116.55, 120.83, 
125.88, 128.58, 128.64, 129.46, 129.97, 131.09, 134.72, 
135.92, 140.49, 145.14, 149.20, 154.40; MS (ESI), m/z: 
369(M+1)+. Elemental anal. For C14H8Cl3N5O (%), 
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calculated: C, 45.62; H, 2.19; N, 19.00; found: C, 45.65; H, 
2.33; N, 19.21.
8-Chloro-N′-(2-methylbenzylidene)-[1,2,4]triazolo[4,3-
a]pyridine-3-carbohydrazide (4o) white yellow crys-
tal, yield 86 %, m.p. >300 °C; FT-IR (KBr, cm−1): ν 3222, 
3060, 1680, 1598, 1548, 1523, 1488, 1454, 1359, 1234, 
1222, 1112, 1085, 1039, 949, 849, 784, 742, 693; 1H NMR 
(DMSO-d6, 500 MHz), δ: 2.37(s, 3H, CH3), 7.24–7.28(m, 
1H, Ar), 7.37(t, J = 7.5 Hz, 1H, Py), 7.53(d, J = 7.5 Hz, 1H, 
Ar), 7.57(s, 1H, Ar), 7.73(d, J =  7.2 Hz, 1H, Py), 7.84(d, 
J = 7.2 Hz, 1H, Py), 8.51(s, 1H, CH), 9.21(d, J = 6.9 Hz, 
1H, Py), 12.91(s, 1H, NH); 13C NMR (150 MHz, DMSO-
d6) δ 21.35, 116.43, 120.79, 125.15, 125.88, 128.06, 129.29, 
129.33, 131.62, 134.52, 138.66, 140.59, 149.13, 150.21, 
154.21; MS (ESI), m/z: 315(M+1)+. Elemental anal. For 
C15H12ClN5O (%), calculated: C, 57.42; H, 3.86; N, 22.32; 
found: C, 57.38; H, 4.01; N, 22.11.
8-Chloro-N′-(4-(trifluoromethyl)benzylidene)-[1,2,4]
triazolo[4,3-a]pyridine-3-carbohydrazide (4p) white yel-
low crystal, yield 92 %, m.p. >300 °C; FT-IR (KBr, cm−1): 
ν 3321, 3153, 1673, 1620, 1545, 1523, 1487, 1449, 1331, 
1297, 1216, 1153, 1116, 1069, 1018, 952, 838, 794, 743; 1H 
NMR (DMSO-d6, 500 MHz), δ: 7.28(t, J = 7.2 Hz, 1H, Py), 
7.82–7.85(m, 3H, Ar and Py), 7.97(d, J = 8.0 Hz, 2H, Ar) 
8.72(s, 1H, CH), 9.21(d, J = 6.9 Hz, 1H, Py), 13.02(s, 1H, 
NH); 13C NMR (150 MHz, DMSO-d6) δ 116.55, 120.82, 
125.89, 126.21, 126.31, 128.36, 129.46, 138.53, 140.51, 
148.32, 148.36, 149.20, 154.44; 19F NMR (564  MHz, 
DMSO-d6) δ -61.19; MS (ESI), m/z: 368(M+1)+. Elemen-
tal anal. For C15H9ClF3N5O (%), calculated: C, 48.99; H, 
2.47; N, 19.05; found: C, 49.21; H, 2.72; N, 18.88.
8-Chloro-N′-(4-methylbenzylidene)-[1,2,4]triazolo[4,3-
a]pyridine-3-carbohydrazide (4q) white yellow crys-
tal, yield 88 %, m.p. >300 °C; FT-IR (KBr, cm−1): ν 3294, 
3143, 1694, 1671, 1605, 1541, 1509, 1488, 1459, 1357, 
1233, 1220, 1152, 1074, 1043, 953, 910, 842, 813, 743; 1H 
NMR (DMSO-d6, 500 MHz), δ: 2.36(s, 3H, CH3), 6.68(t, 
J = 7.5 Hz, 1H, Py), 7.65(d, J = 7.5 Hz, 2H, Ar), 7.85(d, 
J =  7.4 Hz, 2H, Ar), 8.07(d, J =  4.4 Hz, 1H, Py), 8.51(s, 
1H, CH), 9.21(d, J =  6.9 Hz, 1H, Py), 12.78(s, 1H, NH); 
13C NMR (150 MHz, DMSO-d6) δ 21.55, 116.41, 120.78, 
125.88, 127.77, 129.32, 130.01, 131.06, 140.62, 140.81, 
149.12, 150.17, 154.15; MS (ESI), m/z: 314(M+1)+. Ele-
mental anal. For C15H12ClN5O (%), calculated: C, 57.42; 
H, 3.86; N, 22.32; found: C, 57.65; H, 3.03; N, 22.55.
Antifungal activity
Antifungal activities of compounds 4a–4q against 
Stemphylium lycopersici (Enjoji) Yamamoto, Fusarium 
oxysporum. sp. Cucumebrium and Botrytis cinerea were 
determined according to our previous work [31]. The 
potted plants cucumber and tomato were used. The 
determine concentration of control zhongshengmycin, 
thiophanate-methyl, cyprodinil and the title compounds 
is 100 μg/mL. The three fungals Stemphylium lycopersici 
(Enjoji) Yamamoto, Fusarium oxysporum. sp. Cucume-
brium and Botrytis cinerea were inoculated when the 
cucumber or tomato is at the stage of two seed leaves. 
The relative control efficacy of compounds comparing to 
the blank assay was calculated via the following equation:
 where CK is the average disease index during the blank 
assay and PT is the average disease index after treatment 
during testing. All experiments were replicated three 
times.
Therotical calculations
The theoretical calculation was carried out using DFT 
methods. The geometry optimization of compound 4c 
and 4k was carried out at the B3LYP/6-31G level. The 
energies of HOMO, LUMO and total energy, energy gap 
are calculated. All these are carried out using the Gauss-
ian 03 package [32] on the dell computer. The LogP was 
calculated by Chemdraw 7.0.
Conclusions
In conclusion, a series of novel 1,2,4-triazolo[4,3-a]pyri-
dine derivatives containing hydrazone moiety have been 
designed by bio-rational method based on the former 
lead compound by us. Many compounds were found to 
show good antifungal activity. The further comprehen-
sive structure-active relationship was described by using 
theoretical calculation method. Among them, compound 
4k possessed excellent antifungal activities against Stem-
phylium lycopersici (Enjoji) Yamamoto and Fusarium 
oxysporum. sp. Cucumebrium.
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